Neesse Albrecht, Michl Patrick, Kunsch Steffen, Ellenrieder Volker, Gress Thomas M, Steinkamp Martin
Division of Gastroenterology and Endocrinology, IBD Centre, Philipps University Marburg, Marburg, Germany.
Case Rep Gastroenterol. 2007 Oct 12;1(1):110-5. doi: 10.1159/000108637.
Pyoderma gangrenosum (PG) is an immune-mediated inflammatory skin condition representing one of the most distinct extraintestinal manifestations of inflammatory bowel disease (IBD). PG occurs independently from intestinal disease activity in about 1-2% of patients suffering from ulcerative colitis or Crohn's disease and is characterized by chronic deep skin ulcers whose exact pathogenesis is still unknown. So far, patients with ulcerative colitis have only been reported to develop PG during the course of IBD but not at the initial manifestation of bowel symptoms. This is the first report demonstrating the simultaneous onset of ulcerative colitis and severe multifocal PG. In addition, we provide first evidence that infliximab may have a particularly powerful effect in early disseminated PG compared to late-onset PG, advocating an early application of this drug.
坏疽性脓皮病(PG)是一种免疫介导的炎症性皮肤病,是炎症性肠病(IBD)最独特的肠外表现之一。在约1%-2%的溃疡性结肠炎或克罗恩病患者中,PG独立于肠道疾病活动而发生,其特征为慢性深部皮肤溃疡,确切发病机制尚不清楚。迄今为止,仅报道过溃疡性结肠炎患者在IBD病程中发生PG,而非在肠道症状初发时出现。这是首例证明溃疡性结肠炎与严重多灶性PG同时发病的报告。此外,我们首次提供证据表明,与迟发性PG相比,英夫利昔单抗在早期播散性PG中可能具有特别强效的作用,提倡早期应用该药。